HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.
Yan S, Xiong H, Shao F, Zhang W, Yang F, Qi Z, Chen S, He L, Jiang M, Su Y, Zhu H, Qin S, Zhu Q, Luo X, Xing Q.
Yan S, et al. Among authors: xing q.
Pharmacogenomics J. 2019 Jun;19(3):277-285. doi: 10.1038/s41397-018-0051-3. Epub 2018 Sep 20.
Pharmacogenomics J. 2019.
PMID: 30237582